<DOC>
	<DOCNO>NCT02374957</DOCNO>
	<brief_summary>Twenty patient recruit CLEAR . Ten randomize treatment arm ( Cilostazol ) tenwill randomize control group . Patients randomize treatment arm receive Cilostazol 90 day . The primary purpose study collect quality life data patient undergoing peripheral revascularization order determine sample size require adequately power trial Cilostazol versus usual care without Cilostazol effect quality life .</brief_summary>
	<brief_title>Cilostazol After Lower Extremity Arterial Revascularization Trial</brief_title>
	<detailed_description>Cilostazol medication approve use peripheral arterial disease ( PAD ) patient reduce claudication symptom . Contemporary data demonstrate Cilostazol improve patency endovascular intervention multiple randomized trial retrospective study do Japan critical limb ischemia claudication patient . However , Cilostazol use peripheral revascularization sporadic research estimate patient quality life use Cilostazol open endovascular lower extremity revascularization . This prospective investigator initiate single-center open-label , non-placebo control pilot study . Eligible patient would randomize either Cilostazol treatment non-Cilostazol treatment group use close envelope randomization technique . Twenty patient recruited randomize ; Ten treatment group tento control group . The primary purpose pilot study collect quality life data patient undergoing peripheral revascularization order determine sample size required adequate power trial Cilostazol versus usual care without Cilostazol effect Quality Life .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>At least 35 year age Atherosclerotic peripheral arterial disease Able provide inform consent Lower extremity open endovascular revascularization . Known CHF ( class III/IV ) Allergic reaction phosphodiasterase inhibitor Intracranial bleeding within 3 month active bleed peptic ulcer disease Traumatic vascular injury require revascularization Pregnant breast feed woman woman plan get pregnant study period Planned ipsilateral major amputation within 30 day index procedure Moderate severe hepatic impairment .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>leg pain</keyword>
	<keyword>claudication</keyword>
</DOC>